Professional Summary
Education & Certifications
- Medical Education: Virginia Commonwealth University School of Medicine Registrar (1978) VA
- Residency: West Virginia University Hospital (1981) WV
- Fellowship: University of Rochester (1983) NY
- Board Certification: American Board of Internal Medicine, Nephrology (1984)
- Board Certification: American Board of Internal Medicine, Internal Medicine (1981)
- M.D., Medical College of Virginia (1978)
- A.B., Davidson College, Psychology (1974)
Administrative Appointments
- Medical Director, Stanford Adult Kidney and Pancreas Transplantation (1992 - 2022)
- Program Director, Stanford Nephrology Fellowship Training Program (2005 - 2017)
- Program Director, Stanford Transplant Nephrology Fellowship Training Program (2006 - 2020)
Publications
-
Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft
Kwon, O., Corrigan, G., Myers, B. D., Sibley, R., Scandling, J. D., Dafoe, D., … NELSON, W. J. (1999). Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft. KIDNEY INTERNATIONAL, 55(3), 963–75. -
Power Doppler imaging of acute renal transplant rejection
Sidhu, M. K., Gambhir, S., Jeffrey, R. B., Sommer, F. G., Li, K. C. P., Krieger, N. R., … Scandling, J. D. (1999). Power Doppler imaging of acute renal transplant rejection. JOURNAL OF CLINICAL ULTRASOUND, 27(4), 171–75. -
PAH extraction and estimation of plasma flow in human postischemic acute renal failure
Corrigan, G., Ramaswamy, D., Kwon, O., Sommer, F. G., Alfrey, E. J., Dafoe, D. C., … Myers, B. D. (1999). PAH extraction and estimation of plasma flow in human postischemic acute renal failure. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 277(2), F312–F318. -
Revisiting the use of hepatitis B core antibody-positive donor kidneys
Krieger, N. R., Vial, C. M., Millan, M. T., Imperial, J., Dafoe, D. C., & Scandling, J. D. (2001). Revisiting the use of hepatitis B core antibody-positive donor kidneys. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1535–1536. -
Maintenance and recovery stages of postischemic acute renal failure in humans
Ramaswamy, D., Corrigan, G., Polhemus, C., Boothroyd, D., Scandling, J., Sommer, F. G., … Myers, B. D. (2002). Maintenance and recovery stages of postischemic acute renal failure in humans. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 282(2), F271–F280. -
Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation
Millan, T. L. T., Shizuru, J. A., Hoffmann, P., Dejbakhsh-Jones, S., Scandling, J. D., GRUMET, F. C., … Strober, S. (2002). Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. TRANSPLANTATION, 73(9), 1386–91. -
Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?
Yorgin, P. D., Scandling, J. D., Belson, A., Sanchez, J., Alexander, S. R., & Andreoni, K. A. (2002). Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem? AMERICAN JOURNAL OF TRANSPLANTATION, 2(5), 429–35. -
Quantification of immunosuppression by flow cytometry in stable renal transplant recipients
Stalder, M., Birsan, T., Holm, B., Haririfar, M., Scandling, J., & Morris, R. E. (2003). Quantification of immunosuppression by flow cytometry in stable renal transplant recipients. THERAPEUTIC DRUG MONITORING, 25(1), 22–27. -
Increased expression of cytotoxic effector molecules: Different interpretations for steroid-based and steroid-free immunosuppression
Satterwhite, T., Chua, M. S., Hsieh, S. C., Chang, S., Scandling, J., Salvatierra, O., & Sarwal, M. M. (2003). Increased expression of cytotoxic effector molecules: Different interpretations for steroid-based and steroid-free immunosuppression. PEDIATRIC TRANSPLANTATION, 7(1), 53–58. -
A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF
Hladunewich, M. A., Corrigan, G., Derby, G. C., Ramaswamy, D., Kambham, N., Scandling, J. D., & Myers, B. D. (2003). A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF. KIDNEY INTERNATIONAL, 64(2), 593–602. -
GLOMERULAR SIZE-SELECTIVITY AND MICROALBUMINURIA IN EARLY DIABETIC GLOMERULAR-DISEASE
Scandling, J. D., & Myers, B. D. (1992). GLOMERULAR SIZE-SELECTIVITY AND MICROALBUMINURIA IN EARLY DIABETIC GLOMERULAR-DISEASE. KIDNEY INTERNATIONAL, 41(4), 840–846. -
Approaches to transplantation tolerance in humans
Strober, S., Lowsky, R. J., Shizuru, J. A., Scandling, J. D., & Millan, M. T. (2004). Approaches to transplantation tolerance in humans. TRANSPLANTATION, 77(6), 932–36. -
Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: Three-year results
Burke, G. W., Kaufman, D. B., Millis, J. M., Gaber, A. O., Johnson, C. P., Sutherland, D. E. R., … Fitzsimmons, W. E. (2004). Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: Three-year results. TRANSPLANTATION. WASHINGTON,DC,DC,DC,DC: LIPPINCOTT WILLIAMS & WILKINS. -
Dual-kidney transplantation with organs from expanded criteria donors: A long-term follow-up
Tan, J. C., Alfrey, E. J., Dafoe, D. C., Millan, M. T., & Scandling, J. D. (2004). Dual-kidney transplantation with organs from expanded criteria donors: A long-term follow-up. TRANSPLANTATION, 78(5), 692–96. -
Renal juxtaglomerular apparatus hyperplasia
Troxell, M. L., Scandling, J. D., & Sibley, R. K. (2005). Renal juxtaglomerular apparatus hyperplasia. NEPHROLOGY DIALYSIS TRANSPLANTATION, 20(10), 2282–2283. -
Kidney transplant candidate evaluation
Scandling, J. D. (2005). Kidney transplant candidate evaluation. SEMINARS IN DIALYSIS, 18(6), 487–94. -
ATRIAL-NATRIURETIC-PEPTIDE AND RESPONSE TO CHANGING PLASMA-VOLUME IN DIABETIC NEPHROPATHY
Lieberman, J. S., Parra, L., Newton, L., Scandling, J. D., LOON, N., & Myers, B. D. (1991). ATRIAL-NATRIURETIC-PEPTIDE AND RESPONSE TO CHANGING PLASMA-VOLUME IN DIABETIC NEPHROPATHY. DIABETES, 40(7), 893–901. -
Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation
Ma, I. W. Y., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D. C., Alfrey, E. J., … Scandling, J. D. (2006). Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. CLINICAL TRANSPLANTATION, 20(2), 139–46. -
High rates of coronary artery stenosis detected by angiography in diabetic renal transplant candidates
Scandling, J. D. (2007). High rates of coronary artery stenosis detected by angiography in diabetic renal transplant candidates. NATURE CLINICAL PRACTICE NEPHROLOGY, 3(4), 194–95. -
Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis
Yabu, J. M., Ho, B., Scandling, J. D., & Vincenti, F. (2008). Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. AMERICAN JOURNAL OF TRANSPLANTATION, 8(1), 222–227. -
Tolerance and chimerism after renal and hematopoietic-cell transplantation.
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., Shizuru, J. A., … Strober, S. (2008). Tolerance and chimerism after renal and hematopoietic-cell transplantation. New England Journal of Medicine, 358(4), 362–68. -
United Network for Organ Sharing (UNOS) Organ Allocation Policy and Kidney Utilization
Scandling, J. D., & Norman, D. J. (2010). United Network for Organ Sharing (UNOS) Organ Allocation Policy and Kidney Utilization. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(1), 7–9. -
Living donor evaluation and exclusion: the Stanford experience
Lapasia, J. B., Kong, S.-yee, Busque, S., Scandling, J. D., Chertow, G. M., & Tan, J. C. (2011). Living donor evaluation and exclusion: the Stanford experience. CLINICAL TRANSPLANTATION, 25(5), 697–704. -
Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Sarwal, M., Millan, M. T., … Strober, S. (2012). Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 12(5), 1133–45. -
Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation.
Lenihan, C. R., Montez-Rath, M. E., Scandling, J. D., Turakhia, M. P., & Winkelmayer, W. C. (2013). Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. American Journal of Transplantation , 13(6), 1566–75. -
CLINICAL OUTCOME OF INTERVAL CADAVERIC RENAL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS
Kuo, P. C., Luikart, H., BUSSEHENRY, S., Hunt, S. A., Valantine, H. A., Stinson, E. B., … Dafoe, D. C. (1995). CLINICAL OUTCOME OF INTERVAL CADAVERIC RENAL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS. CLINICAL TRANSPLANTATION, 9(2), 92–97. -
ENDOGENOUS ANP IN POSTISCHEMIC ACUTE RENAL-ALLOGRAFT FAILURE
VINOT, O., Bialek, J., CANAANKUHL, S., Scandling, J. D., Dafoe, D., Alfrey, E., & Myers, B. D. (1995). ENDOGENOUS ANP IN POSTISCHEMIC ACUTE RENAL-ALLOGRAFT FAILURE. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 269(1), F125–F133. -
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND EPSTEIN-BARR-VIRUS PROPHYLAXIS
Kuo, P. C., Dafoe, D. C., Alfrey, E. J., Sibley, R. K., & Scandling, J. D. (1995). POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND EPSTEIN-BARR-VIRUS PROPHYLAXIS. TRANSPLANTATION, 59(1), 135–138. -
MECHANISMS OF FILTRATION FAILURE DURING POSTISCHEMIC INJURY OF THE HUMAN KIDNEY - A STUDY OF THE REPERFUSED RENAL-ALLOGRAFT
ALEJANDRO, V., Scandling, J. D., Sibley, R. K., Dafoe, D., Alfrey, E., Deen, W., & Myers, B. D. (1995). MECHANISMS OF FILTRATION FAILURE DURING POSTISCHEMIC INJURY OF THE HUMAN KIDNEY - A STUDY OF THE REPERFUSED RENAL-ALLOGRAFT. JOURNAL OF CLINICAL INVESTIGATION, 95(2), 820–31. -
THE USE OF SPIRAL COMPUTED-TOMOGRAPHY IN THE EVALUATION OF LIVING DONORS FOR KIDNEY-TRANSPLANTATION
Alfrey, E. J., Rubin, G. D., Kuo, P. C., WASKERWITZ, J. A., Scandling, J. D., MELL, M. W., … Dafoe, D. C. (1995). THE USE OF SPIRAL COMPUTED-TOMOGRAPHY IN THE EVALUATION OF LIVING DONORS FOR KIDNEY-TRANSPLANTATION. TRANSPLANTATION, 59(4), 643–45. -
ENDOVASCULAR STENTING OF THE ABDOMINAL-AORTA FOLLOWING RENAL-TRANSPLANTATION
Kuo, P. C., Alfrey, E. J., Scandling, J. D., Dake, M., & Dafoe, D. C. (1994). ENDOVASCULAR STENTING OF THE ABDOMINAL-AORTA FOLLOWING RENAL-TRANSPLANTATION. TRANSPLANTATION, 58(4), 522–24. -
SPIRAL COMPUTED-TOMOGRAPHY IN THE DIAGNOSIS OF TRANSPLANT RENAL-ARTERY STENOSIS
MELL, M. W., Alfrey, E. J., Rubin, G. D., Scandling, J. D., Jeffrey, R. B., & Dafoe, D. C. (1994). SPIRAL COMPUTED-TOMOGRAPHY IN THE DIAGNOSIS OF TRANSPLANT RENAL-ARTERY STENOSIS. TRANSPLANTATION, 57(5), 746–48. -
POSTISCHEMIC INJURY, DELAYED FUNCTION AND NA+/K+-ATPASE DISTRIBUTION IN THE TRANSPLANTED KIDNEY
ALEJANDRO, V. S. J., NELSON, W. J., Huie, P., Sibley, R. K., Dafoe, D., Kuo, P., … Myers, B. D. (1995). POSTISCHEMIC INJURY, DELAYED FUNCTION AND NA+/K+-ATPASE DISTRIBUTION IN THE TRANSPLANTED KIDNEY. KIDNEY INTERNATIONAL, 48(4), 1308–1315. -
THE UTILITY OF RETROPERITONEAL KIDNEY PLACEMENT IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION
Kuo, P. C., Krieger, N. R., Alfrey, E. J., Scandling, J., & Dafoe, D. C. (1995). THE UTILITY OF RETROPERITONEAL KIDNEY PLACEMENT IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION. CLINICAL TRANSPLANTATION, 9(6), 457–462. -
The kidneys that nobody wanted - Support for the utilization of expanded criteria donors
Lee, C. M., Scandling, J. D., Shen, G. K., Salvatierra, O., Dafoe, D. C., & Alfrey, E. J. (1996). The kidneys that nobody wanted - Support for the utilization of expanded criteria donors. TRANSPLANTATION, 62(12), 1832–41. -
Use of an augmented urinary bladder can be catastrophic in renal transplantation
Alfrey, E. J., Conley, S. B., Tanney, D. C., Mak, R., Scandling, J. D., Dafoe, D. C., … Salvatierra, O. (1997). Use of an augmented urinary bladder can be catastrophic in renal transplantation. TRANSPLANTATION PROCEEDINGS, 29(1-2), 154–55. -
Pathophysiology of reduced glomerular filtration rate in delayed graft function
Scandling, J. D., & Myers, B. D. (1997). Pathophysiology of reduced glomerular filtration rate in delayed graft function. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 6(4), 405–409. -
Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation
Shen, G. K., Alfrey, E. J., Knoppel, C. L., Dafoe, D. C., & Scandling, J. D. (1997). Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation. TRANSPLANTATION, 64(6), 931–933. -
When should expanded criteria donor kidneys be used for single versus dual kidney transplants?
Alfrey, E. J., Lee, C. M., Scandling, J. D., Pavlakis, M., Markezich, A. J., & Dafoe, D. C. (1997). When should expanded criteria donor kidneys be used for single versus dual kidney transplants? TRANSPLANTATION, 64(8), 1142–46. -
Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation
Lee, C. M., Scandling, J. D., Krieger, N. R., Dafoe, D. C., & Alfrey, E. J. (1997). Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation. TRANSPLANTATION, 64(9), 1288–94. -
Expanded criteria for donor kidneys: An update on outcome in single versus dual kidney transplants
Alfrey, E. J., Lee, C. M., Scandling, J. D., Witter, M. M., Carter, J. T., Markezich, A. J., … Dafoe, D. C. (1997). Expanded criteria for donor kidneys: An update on outcome in single versus dual kidney transplants. TRANSPLANTATION PROCEEDINGS, 29(8), 3671–73. -
Bladder augmentation can be problematic with renal failure and transplantation
Alfrey, E. J., Salvatierra, O., Tanney, D. C., Mak, R., Scandling, J. D., Dafoe, D. C., … Conley, S. B. (1997). Bladder augmentation can be problematic with renal failure and transplantation. PEDIATRIC NEPHROLOGY, 11(6), 672–75. -
A review of the kidneys that nobody wanted
Lee, C. M., Scandling, J. D., Pavlakis, M., Markezich, A. J., Dafoe, D. C., & Alfrey, E. J. (1998). A review of the kidneys that nobody wanted. TRANSPLANTATION, 65(2), 213–19. -
Backleak, light junctions, and cell-cell adhesion in postischemic injury to the renal allograft
Kwon, O., NELSON, W. J., Sibley, R., Huie, P., Scandling, J. D., Dafoe, D., … Myers, B. D. (1998). Backleak, light junctions, and cell-cell adhesion in postischemic injury to the renal allograft. JOURNAL OF CLINICAL INVESTIGATION, 101(10), 2054–64. -
Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation
Desai, D. M., Scandling, J. D., Knoppel, C., Dafoe, D. C., & Alfrey, E. J. (1998). Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation. TRANSPLANTATION PROCEEDINGS, 30(4), 1552–1554. -
What is the optimal approach for the end-stage diabetic nephropathy patient considering simultaneous pancreas-kidney transplantation?
Dafoe, D. C., Scandling, J. D., WASKERWITZ, J. A., & Beinin, M. L. (1998). What is the optimal approach for the end-stage diabetic nephropathy patient considering simultaneous pancreas-kidney transplantation? Advances in Renal Replacement Therapy, 5(3), 232–240. -
Plasma glutathione peroxidase and its relationship to renal proximal tubule function
Whitin, J. C., Tham, D. M., Bhamre, S., Ornt, D. B., Scandling, J. D., Tune, B. M., … Cohen, H. J. (1998). Plasma glutathione peroxidase and its relationship to renal proximal tubule function. MOLECULAR GENETICS AND METABOLISM, 65(3), 238–45. -
Kidney and kidney/pancreas transplantation at Stanford University Medical Center.
Desai, D. M., Scandling, J. D., Alfrey, E. J., Pavlakis, M., Salvatierra, O., Conley, S. B., … Dafoe, D. C. (1997). Kidney and kidney/pancreas transplantation at Stanford University Medical Center. Clinical Transplants, 135–147. -
Final renal function outcomes from the spare-the-nephron (STN) trial: Mycophenolate mofetil (MMF)/sirolimus (SRL) maintenance therapy and CNI withdrawal in renal transplant recipients
Mulgaonkar, S., Pearson, T. C., Patel, A., Scandling, J., Shidban, H., Weir, M., & Patel, D. (2008). Final renal function outcomes from the spare-the-nephron (STN) trial: Mycophenolate mofetil (MMF)/sirolimus (SRL) maintenance therapy and CNI withdrawal in renal transplant recipients. Presented at the 8th American Transplant Congress, TORONTO,CANADA,CANADA: WILEY-BLACKWELL. -
Efficacy and safety of mycophenolate mofetil (MMF)/sirolimus (SRL) maintenance therapy after calcineurin inhibitor (CNI) withdrawal in renal transplant recipients: Final results of the spare-the-nephron (STN) trial.
Pearson, T. C., Mulgaonkar, S., Patel, A., Scandling, J., Shidban, H., Weir, M., & Patel, D. (2008). Efficacy and safety of mycophenolate mofetil (MMF)/sirolimus (SRL) maintenance therapy after calcineurin inhibitor (CNI) withdrawal in renal transplant recipients: Final results of the spare-the-nephron (STN) trial. Presented at the 8th American Transplant Congress, TORONTO,CANADA,CANADA: WILEY-BLACKWELL. -
CNI Withdrawal in African Americans-1 Year Outcomes of African American Renal Transplant Recipients in the Spare-the-Nephron (STN) Trial
Pearson, T., Mulgaonkar, S., Kalil, R., Patel, A., Scandling, J., Patel, D., … Weir, M. (2009). CNI Withdrawal in African Americans-1 Year Outcomes of African American Renal Transplant Recipients in the Spare-the-Nephron (STN) Trial. Presented at the 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, BOSTON,MA,MA: WILEY-BLACKWELL. -
Mycophenolate Mofetil/Sirolimus Maintenance Therapy after Calcineurin Inhibitor Withdrawal in Renal Transplant Recipients: 2-Year Outcomes of the Spare-the-Nephron (STN) Trial.
Weir, M., Mulgaonkar, S., Pearson, T., Patel, A., Patel, D., Shidban, H., & Scandling, J. (2009). Mycophenolate Mofetil/Sirolimus Maintenance Therapy after Calcineurin Inhibitor Withdrawal in Renal Transplant Recipients: 2-Year Outcomes of the Spare-the-Nephron (STN) Trial. Presented at the 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, BOSTON,MA,MA: WILEY-BLACKWELL. -
VASODILATOR UNRESPONSIVENESS OF ACUTE POSTISCHEMIC RENAL-ALLOGRAFT FAILURE
Tse, E., VINOT, O., Huie, P., Sibley, R. K., Wang, B. Y., Cooke, J. P., … Myers, B. D. (1995). VASODILATOR UNRESPONSIVENESS OF ACUTE POSTISCHEMIC RENAL-ALLOGRAFT FAILURE. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(3), 478–478. -
A pharmacokinetic conversion study of Abbott cyclosporine and Neoral((R)) in stable renal transplant recipients
Tomlanovich, S., Pollak, R., Roza, A., Merion, R., Scandling, J., Greco, R., … Nabulsi, A. (1999). A pharmacokinetic conversion study of Abbott cyclosporine and Neoral((R)) in stable renal transplant recipients. TRANSPLANTATION, 67(7), S163–S163. -
A Highly Specific Novel 3 Gene-Set Can Non-Invasively Predict Operational Renal Allograft Tolerance.
Li, L., Heish, S., Scandling, J., Sigdel, T., & Sarwal, M. (2010). A Highly Specific Novel 3 Gene-Set Can Non-Invasively Predict Operational Renal Allograft Tolerance. Presented at the 10th American Transplant Congress, SAN DIEGO,CA,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL. -
Uniform Long-Term Graft Survival in a Clincial Trial of the Induction of Tolerance to Kidney Transplants.
Scandling, J., Busque, S., Shori, A., Dejbakhsh-Jones, S., Shizuru, J., Lowsky, R., … Strober, S. (2013). Uniform Long-Term Graft Survival in a Clincial Trial of the Induction of Tolerance to Kidney Transplants. Presented at the 13th American Transplant Congress (ATC), SEATTLE,WA,WA,WA: WILEY-BLACKWELL. -
Tolerance induction using combined organ and hematopoietic cell transplantation following TLI/ATG conditioning.
Lowsky, R., MILLAN, M., Scandling, J., Shizuru, J., & Strober, S. (2004). Tolerance induction using combined organ and hematopoietic cell transplantation following TLI/ATG conditioning. BLOOD CELLS MOLECULES AND DISEASES, 33(3), 203–204. -
Gene Arrays May Predict Stable Clinical Kidney Tolerance and Support Safe Immunosuppression Withdrawal
Sarwal, M. M., Li, L., Hsieh, S.-C., Lowsky, R., Busque, S., Scandling, J., … Strober, S. (2010). Gene Arrays May Predict Stable Clinical Kidney Tolerance and Support Safe Immunosuppression Withdrawal. Presented at the American-Society-of-Transplantation Annual Scientific Exchange, ORLANDO,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL,FL: WILEY-BLACKWELL PUBLISHING, INC. -
Successful Tolerance Induction with a Post KidneyTransplantation (Tx) Regimen of Total Lymphoid Irradiation (TLI), Antithymocyte Globulin (ATG) and Donor Purified CD34 Progenitor Cells in HLA-Matched Recipients
Busque, S., Scandling, J. D., Dejbakhsh-Jones, S., Shizuru, J. A., Lowsky, R., Benike, C., … Srober, S. (2011). Successful Tolerance Induction with a Post KidneyTransplantation (Tx) Regimen of Total Lymphoid Irradiation (TLI), Antithymocyte Globulin (ATG) and Donor Purified CD34 Progenitor Cells in HLA-Matched Recipients. Presented at the American Transplant Congress, PHILADELPHIA,PA,PA: WILEY-BLACKWELL. -
Chimerism and Tolerance after Combined Human Kidney and Hematopoietic Cell Transplantation Using Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin
Lowsky, R., Shizuru, J., Busque, S., Scandling, J., Sarwal, M., Jones, S., … Strober, S. (2008). Chimerism and Tolerance after Combined Human Kidney and Hematopoietic Cell Transplantation Using Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin. BLOOD, 112(11), 758–58. -
Changes in T Cell Subsets in 12 Patients Enrolled in a Tolerance Induction Protocol with Combined Kidney and Hematopoietic Cell Transplantation.
Dejbakhsh-Jones, S., Takahashi, K., Jensen, K. P., Busque, S., Scandling, J. D., Shizuru, J., … Strober, S. (2011). Changes in T Cell Subsets in 12 Patients Enrolled in a Tolerance Induction Protocol with Combined Kidney and Hematopoietic Cell Transplantation. Presented at the American Transplant Congress, PHILADELPHIA,PA,PA: WILEY-BLACKWELL. -
Favorable outcome after interval kidney transplantation in heart transplant recipients
Chan, M. C. Y., Lam, C. W., Scandling, J., Valentine, H. A., & Hunt, S. A. (2001). Favorable outcome after interval kidney transplantation in heart transplant recipients. CIRCULATION, 104(17), 364–364. -
Current prevalence of coronary artery disease in kidney transplant candidates with type I diabetes mellitus.
Ma, I. W. Y., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D., Alfrey, E., … Scandling, J. D. (2002). Current prevalence of coronary artery disease in kidney transplant candidates with type I diabetes mellitus. AMER SOC NEPHROLOGY. -
The consequences of delayed graft function (DGF) after kidney transplantation
Hwang, C. S., Tan, J. C., Scandling, J. D., & Alfrey, E. J. (2007). The consequences of delayed graft function (DGF) after kidney transplantation. WILEY-BLACKWELL. -
Donors with Kidney Stones: Should We Pass?
Kim, I. K., Lapasia, J., Elihu, A., Tan, J., Scandling, J., Busque, S., & Melcher, M. (2011). Donors with Kidney Stones: Should We Pass? Presented at the Congress of the American-Society-of-Transplant-Surgeons, SAN DIEGO,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL PUBLISHING, INC. -
Impact of Short Term Pre-Transplant Dialysis on Kidney Transplant Outcomes
Javaid, B., Kim, J.-Y., Yabu, J., Tan, J., Melcher, M., Busque, S., & Scandling, J. (2010). Impact of Short Term Pre-Transplant Dialysis on Kidney Transplant Outcomes. Presented at the 10th American Transplant Congress, SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL. -
A Retrospective Analysis of Practices in Living Donor Evaluation and Exclusion.
Lapasia, J., Scandling, J. D., Javaid, B., Busque, S., & Tan, J. C. (2010). A Retrospective Analysis of Practices in Living Donor Evaluation and Exclusion. Presented at the 10th American Transplant Congress, SAN DIEGO,CA: WILEY-BLACKWELL. -
Validation of a screening protocol for coronary artery disease in kidney and/or pancreas transplant candidates with type I diabetes mellitus.
Ma, I. W. Y., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D., Alfrey, E., … Scandling, J. D. (2002). Validation of a screening protocol for coronary artery disease in kidney and/or pancreas transplant candidates with type I diabetes mellitus. AMER SOC NEPHROLOGY. -
Risk of Graft Failure Due to Disease Recurrence in Patients with FSGS
Kim, J.-Y., Yabu, J., Tan, J., Scandling, J., Melcher, M., Busque, S., & Javaid, B. (2010). Risk of Graft Failure Due to Disease Recurrence in Patients with FSGS. Presented at the 10th American Transplant Congress, SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL. -
Long-term graft survival of older donor kidneys is improved with dual kidney transplantation.
Bhatt, A., Scandling, J. D., Myers, B. D., & Tan, J. C. (2003). Long-term graft survival of older donor kidneys is improved with dual kidney transplantation. Presented at the 36th Annual Meeting of the American-Society-of-Nephrology, SAN DIEGO,CA,CA,CA,CA,CA,CA: AMER SOC NEPHROLOGY. -
Effect of steroid avoidance on early graft function after kidney transplantation
Roozrokh, H. C., Chen, L., Scandling, J. D., Momsen, A., Tan, J., & Busque, S. (2004). Effect of steroid avoidance on early graft function after kidney transplantation. Presented at the 5th American Transplant Congress, BOSTON,MA: WILEY-BLACKWELL. -
A non-myeloablative conditioning regimen followed by progenitor cell (CD34+) infusion after kidney transplantation can achieve mixed chimerism and immunosuppressive drug withdrawal
Millan, M. T., Shizuru, J. A., Hoffmann, P., Dejbakhsh-Jones, S., Scandling, J. D., GRUMET, F. C., … Strober, S. (2002). A non-myeloablative conditioning regimen followed by progenitor cell (CD34+) infusion after kidney transplantation can achieve mixed chimerism and immunosuppressive drug withdrawal. FASEB JOURNAL, 16(5), A1030–A1030. -
LOW-DOSE OKT3 TREATMENT FOR INDUCTION REJECTION IN MULTIORGAN TRANSPLANTATION
DIEKMANNGUIROY, B., Scandling, J. D., BUSSEHENRY, S., Kuo, P. C., Dafoe, D. C., & Alfrey, E. J. (1995). LOW-DOSE OKT3 TREATMENT FOR INDUCTION REJECTION IN MULTIORGAN TRANSPLANTATION. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(3), 1080–1080. -
Gene Arrays May Predict Stable Clinical Tolerance and Support Safe Immunosuppression Withdrawal.
Sarwal, M. M., Li, L., Hsieh, S.-C., Lowsky, R., Busque, S., Scandling, J., … Strober, S. (2009). Gene Arrays May Predict Stable Clinical Tolerance and Support Safe Immunosuppression Withdrawal. Presented at the 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, BOSTON,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA,MA: WILEY-BLACKWELL. -
MECHANISM OF POTASSIUM-DEPLETION DURING CHRONIC METABOLIC-ACIDOSIS IN THE RAT
Scandling, J. D., & Ornt, D. B. (1987). MECHANISM OF POTASSIUM-DEPLETION DURING CHRONIC METABOLIC-ACIDOSIS IN THE RAT. AMERICAN JOURNAL OF PHYSIOLOGY, 252(1), F122–F130. -
Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine
Lee, C. M., Markezich, A. J., Scandling, J. D., Dafoe, D. C., & Alfrey, E. J. (1998). Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine. JOURNAL OF SURGICAL RESEARCH, 76(2), 131–136. -
Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation
Roza, A., Tomlanovich, S., Merion, R., Pollak, R., Wright, F., Rajagopalan, P., … Hoffman, R. (2002). Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation. TRANSPLANTATION, 74(7), 1013–1017. -
PHARMACEUTICAL EXPENSES AFTER KIDNEY AND KIDNEY-PANCREAS TRANSPLANTATION
Kuo, P. C., MELL, D., Alfrey, E. J., Scandling, J., & Dafoe, D. C. (1995). PHARMACEUTICAL EXPENSES AFTER KIDNEY AND KIDNEY-PANCREAS TRANSPLANTATION. TRANSPLANTATION, 59(3), 452–453. -
The role of pre-transplant renal replacement therapy (RRT) modality in kidney allograft and recipient survival
Goldfarb-Rumyantzev, A. S., Hurdle, J. F., Barenbaum, L., Wang, Z., Baird, B., Scandling, J. D., & Cheung, A. K. (2004). The role of pre-transplant renal replacement therapy (RRT) modality in kidney allograft and recipient survival. Presented at the 5th American Transplant Congress, BOSTON,MA: WILEY-BLACKWELL. -
Recommendations for the outpatient surveillance of renal transplant recipients
Kasiske, B. L., Vazquez, M. A., Harmon, W. E., Brown, R. S., Danovitch, G. M., GASTON, R. S., … Singer, G. G. (2000). Recommendations for the outpatient surveillance of renal transplant recipients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 11(10), S1–S86. -
The role of pre-emptive re-transplant in graft and recipient outcome
Goldfarb-Rumyantzev, A. S., Hurdle, J. F., Baird, B. C., Stoddard, G., Wang, Z., Scandling, J. D., … Cheung, A. K. (2006). The role of pre-emptive re-transplant in graft and recipient outcome. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(5), 1355–64. -
Prediction of 3-yr cadaveric graft survival based on pre-transplant variables in a large national dataset
Goldfarb-Rumyantzev, A. S., Scandling, J. D., Pappas, L., Smout, R. J., & Horn, S. (2003). Prediction of 3-yr cadaveric graft survival based on pre-transplant variables in a large national dataset. CLINICAL TRANSPLANTATION, 17(6), 485–497. -
The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival
Goldfarb-Rumyantzev, A. S., Hurdle, J. F., Scandling, J. D., Baird, B. C., & Cheung, A. K. (2005). The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival. AMERICAN JOURNAL OF KIDNEY DISEASES, 46(3), 537–49. -
Duration of end-stage renal disease and kidney transplant outcome
Goldfarb-Rumyantzev, A., Hurdle, J. F., Scandling, J., Wang, Z., Baird, B., Barenbaum, L., & Cheung, A. K. (2005). Duration of end-stage renal disease and kidney transplant outcome. NEPHROLOGY DIALYSIS TRANSPLANTATION, 20(1), 167–75. -
Dual kidney transplantation: Older donors for older recipients
Lee, C. M., Carter, J. T., Weinstein, R. J., Pease, H. M., Scandling, J. D., Pavalakis, M., … Alfrey, E. J. (1999). Dual kidney transplantation: Older donors for older recipients. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 189(1), 82–91. -
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation
Johnson, C., Ahsan, N., Gonwa, T., Halloran, P., Stegall, M., Hardy, M., … Fitzsimmons, W. E. (2000). Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. TRANSPLANTATION. PHILADELPHIA,PA,PA: LIPPINCOTT WILLIAMS & WILKINS. -
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years
Ahsan, N., Johnson, C., Gonwa, T., Halloran, P., Stegall, M., Hardy, M., … Fitzsimmons, W. E. (2001). Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years. TRANSPLANTATION, 72(2), 245–50. -
Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation.
Lenihan, C. R., Montez-Rath, M. E., Shen, J. I., Scandling, J. D., Turakhia, M. P., Chang, T. I., & Winkelmayer, W. C. (2015). Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 30(2), 321–29. -
Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation.
Scandling, J. D., Busque, S., Shizuru, J. A., Lowsky, R., Hoppe, R., Dejbakhsh-Jones, S., … Strober, S. (2015). Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation. American Journal of Transplantation , 15(3), 695–704. -
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine plus mycophenolate mofetill after cadaveric kidney transplantation: Results at three years.
Gonwa, T., Johnson, C., Ahsan, N., Alfrey, E. J., Halloran, P., Stegall, M., … Fitzsimmons, W. E. (2003). Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine plus mycophenolate mofetill after cadaveric kidney transplantation: Results at three years. TRANSPLANTATION, 75(12), 2048–2053. -
ADAPTATION FOR POTASSIUM CONSERVATION DURING DIETARY POTASSIUM DEPRIVATION
Ornt, D. B., Scandling, J. D., & Tannen, R. L. (1987). ADAPTATION FOR POTASSIUM CONSERVATION DURING DIETARY POTASSIUM DEPRIVATION. SEMINARS IN NEPHROLOGY, 7(3), 193–205. -
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.
Kasiske, B. L., Vazquez, M. A., Harmon, W. E., Brown, R. S., Danovitch, G. M., GASTON, R. S., … Singer, G. G. (2000). Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. Journal of the American Society of Nephrology , 11, S1–86. -
Effect of aldosterone on renal potassium conservation in the rat
Ornt, D. B., Radke, K. J., & Scandling, J. D. (1996). Effect of aldosterone on renal potassium conservation in the rat. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 270(6), E1003–E1008. -
POTASSIUM HOMEOSTASIS DURING ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH ENALAPRIL
Scandling, J. D., Izzo, J. L., Pabico, R. C., McKenna, B. A., Radke, K. J., & Ornt, D. B. (1989). POTASSIUM HOMEOSTASIS DURING ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH ENALAPRIL. JOURNAL OF CLINICAL PHARMACOLOGY, 29(10), 916–921. -
A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation
Roedder, S., Li, L., Alonso, M. N., Hsieh, S.-C., Minh Thien Vu, M. T., Dai, H., … Sarwal, M. M. (2015). A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26(8), 2042–53. -
HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States
Perumpail, R. B., Wong, R. J., Scandling, J. D., Ha, L. D., Todo, T., Bonham, C. A., … Ahmed, A. (2015). HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States. CLINICAL TRANSPLANTATION, 29(10), 920–26. -
INFLUENCE OF CADAVERIC ORGAN SOURCE ON DELAYED RENAL-ALLOGRAFT FUNCTION
Scandling, J. D., Izzo, J. L., Ricotta, J. J., & PAPROCKI, S. (1989). INFLUENCE OF CADAVERIC ORGAN SOURCE ON DELAYED RENAL-ALLOGRAFT FUNCTION. TRANSPLANTATION, 47(2), 245–249. -
Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., Shizuru, J. A., … Strober, S. (2008). Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 358(4), 362–68. -
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial
Weir, M. R., Pearson, T. C., Patel, A., Peddi, V. R., Kalil, R., Scandling, J., … Gordon, R. (2017). Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. TRANSPLANTATION, 101(1), 157–65. -
Macrochimerism and clinical transplant tolerance.
Scandling, J. D., Busque, S., Lowsky, R., Shizuru, J., Shori, A., Engleman, E., … Strober, S. (2018). Macrochimerism and clinical transplant tolerance. Human Immunology. -
Detection of coronary artery disease in kidney and/or pancreas transplant candidates with type I diabetes mellitus.
Ma, I. W., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D., Alfrey, E., … Scandling, J. D. (2002). Detection of coronary artery disease in kidney and/or pancreas transplant candidates with type I diabetes mellitus. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13, 192A. -
All's well following living kidney donation?
Scandling, J. D. (2017). All's well following living kidney donation? TRANSPLANT INTERNATIONAL, 30(10), 972–74. -
Immunosuppressive myeloid cells in patients given combined kidney and hematopoietic cell transplants in a tolerance protocol with TLI and ATG conditioning
Jensen, K., Scandling, J., Busque, S., Shizuru, J., Lowsky, R., Saraswathula, A., … Strober, S. (2016). Immunosuppressive myeloid cells in patients given combined kidney and hematopoietic cell transplants in a tolerance protocol with TLI and ATG conditioning. TRANSPLANTATION, 100(7), S5. -
Relationship between mixed chimerism and clinical tolerance after combined kidney and hematopoietic cell transplantation using total lymphoid irradiation and antithymocyte globulin conditioning
Busque, S., Scandling, J. D., Shizuru, J., Lowsky, R., Shori, A., Jensen, K., … Strober, S. (2016). Relationship between mixed chimerism and clinical tolerance after combined kidney and hematopoietic cell transplantation using total lymphoid irradiation and antithymocyte globulin conditioning. TRANSPLANTATION, 100(7), S245. -
Changes in T cell subsets in 12 patients enrolled in a tolerance induction protocol with combined kidney and hematopoietic cell transplantation
Dejbakhsh-Jones, S., Takahashi, K., Jensen, K., Busgue, S., Scandling, J., Shizuru, J., … Strober, S. (2011). Changes in T cell subsets in 12 patients enrolled in a tolerance induction protocol with combined kidney and hematopoietic cell transplantation. JOURNAL OF IMMUNOLOGY, 186. -
A New Approach to Kidney Waitlist Management in the Kidney Allocation System Era: Pilot Implementation and Evaluation.
Cheng, X. S., Busque, S., Lee, J., Discipulo, K., Hartley, C., Tulu, Z., … Tan, J. C. (2018). A New Approach to Kidney Waitlist Management in the Kidney Allocation System Era: Pilot Implementation and Evaluation. Clinical Transplantation, e13406. -
Relationship Between Mixed Chimerism and Acceptance of HLA-matched and -Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs
Busque, S., Scandling, J., Lowsky, R., Shizuru, J., Jensen, K., Shori, A., … Strober, S. (2018). Relationship Between Mixed Chimerism and Acceptance of HLA-matched and -Mismatched Kidney Transplants after Withdrawal of Immunosuppressive Drugs. TRANSPLANTATION, 102, S393. -
Establishing a Core Outcome Measure for Life Participation: a Standardized Outcomes in Nephrology - Kidney Transplantation (SONG-Tx) Consensus Workshop Report.
Ju, A., Josephson, M. A., Butt, Z., Jowsey-Gregoire, S., Tan, J., Taylor, Q., … Tong, A. (2018). Establishing a Core Outcome Measure for Life Participation: a Standardized Outcomes in Nephrology - Kidney Transplantation (SONG-Tx) Consensus Workshop Report. Transplantation. -
Racial/Ethnic Disparities in Simultaneous Liver Kidney Transplantation: An Analysis from the UNOS Database
Perumpail, R. B., Wong, R., Su, A. M., Isom, R., Scandling, J., & Ahmed, A. (2014). Racial/Ethnic Disparities in Simultaneous Liver Kidney Transplantation: An Analysis from the UNOS Database. HEPATOLOGY, 60, 472A–473A. -
DETECTION OF RENAL-TRANSPLANT REJECTION USING POWER DOPPLER IMAGING (PDI)
KRIEGER, N. R., SIDHU, M., SCANDLING, J. D., JEFFREY, R. B., DAFOE, D. C., & ALFREY, E. J. (1995). DETECTION OF RENAL-TRANSPLANT REJECTION USING POWER DOPPLER IMAGING (PDI). JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(3), 1100. -
Rituximab failed to improve nephrotic syndrome in adult renal transplant patients with recurrent focal segmental glomerulosclerosis.
Yabu, J., Ho, B., Scandling, J., & Vincenti, F. (2007). Rituximab failed to improve nephrotic syndrome in adult renal transplant patients with recurrent focal segmental glomerulosclerosis. AMERICAN JOURNAL OF TRANSPLANTATION, 7, 239. -
PAH extraction and estimation of plasma flow in human postischemic acute renal failure.
Corrigan, G., Ramaswamy, D., Kwon, O., Sommer, F. G., Alfrey, E. J., Dafoe, D. C., … Myers, B. D. (1999). PAH extraction and estimation of plasma flow in human postischemic acute renal failure. American Journal of Physiology. Renal Physiology, 277(2), F312–F318. -
DEVELOPING CONSENSUS-BASED PRIORITY OUTCOME DOMAINS FOR TRIALS IN KIDNEY TRANSPLANTATION: A MULTINATIONAL DELPHI SURVEY WITH PATIENTS, CAREGIVERS AND HEALTH PROFESSIONALS
Sautenet, B., Tong, A., Manera, K., Chapman, J., Warrens, A., Rosenbloom, D., … Craig, J. (2017). DEVELOPING CONSENSUS-BASED PRIORITY OUTCOME DOMAINS FOR TRIALS IN KIDNEY TRANSPLANTATION: A MULTINATIONAL DELPHI SURVEY WITH PATIENTS, CAREGIVERS AND HEALTH PROFESSIONALS. TRANSPLANT INTERNATIONAL, 30, 557. -
Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals
Sautenet, B., Tong, A., Manera, K. E., Chapman, J. R., Warrens, A. N., Rosenbloom, D., … Craig, J. C. (2017). Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals. TRANSPLANTATION, 101(8), 1875–86. -
The role of recipient ESRD course and pre-transplant comorbidity in long term kidney allograft survival.
Goldfarb-Rumyantzev, A. S., Wang, Z., Barenbaum, L., & Scandling, J. (2003). The role of recipient ESRD course and pre-transplant comorbidity in long term kidney allograft survival. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14, 665A. -
Diabetes Mellitus is associated with Lower Survival following Simultaneous Liver Kidney Transplantation
Perumpail, R. B., Wong, R., Su, A. M., Tan, J., Scandling, J., & Ahmed, A. (2014). Diabetes Mellitus is associated with Lower Survival following Simultaneous Liver Kidney Transplantation. HEPATOLOGY, 60, 470A. -
Donor and recipient anthropometric characteristics and long term cadaveric kidney allograft outcome.
Goldfarb-Rumyantzev, A. S., Pappas, L., Scandling, J. D., Smout, R. J., & Horn, S. (2002). Donor and recipient anthropometric characteristics and long term cadaveric kidney allograft outcome. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13, 770A. -
A trial of insulin-like growth factor (IgF-1) in delayed transplant allograft function: A model to study postischemic acute renal failure (ARF) in humans
Hladunewich, M. A., Derby, G. C., Corrigan, G., Ramaswamy, D., Thrall, A., Scandling, J. D., & Myers, B. D. (2002). A trial of insulin-like growth factor (IgF-1) in delayed transplant allograft function: A model to study postischemic acute renal failure (ARF) in humans. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13, 445A. -
Tree-based and regression models successfully predict probability of three year cadaveric allograft survival.
Goldfarb-Rumyantzev, A. S., Scandling, J. D., Smout, R. J., Pappas, L., & Horn, S. (2002). Tree-based and regression models successfully predict probability of three year cadaveric allograft survival. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13, 187A. -
Establishing a Core Outcome Measure for Life Participation: A Standardized Outcomes in Nephrology-kidney Transplantation Consensus Workshop Report
Ju, A., Josephson, M. A., Butt, Z., Jowsey-Gregoire, S., Tan, J., Taylor, Q., … Tong, A. (2019). Establishing a Core Outcome Measure for Life Participation: A Standardized Outcomes in Nephrology-kidney Transplantation Consensus Workshop Report. TRANSPLANTATION, 103(6), 1199–1205. -
Macrochimerism and clinical transplant tolerance
Scandling, J. D., Busque, S., Lowsky, R., Shizuru, J., Shori, A., Engleman, E., … Strober, S. (2018). Macrochimerism and clinical transplant tolerance. HUMAN IMMUNOLOGY, 79(5), 266–71. -
A new approach to kidney wait-list management in the kidney allocation system era: Pilot implementation and evaluation
Cheng, X. S., Busque, S., Lee, J., Discipulo, K., Hartley, C., Tulu, Z., … Tan, J. C. (2018). A new approach to kidney wait-list management in the kidney allocation system era: Pilot implementation and evaluation. CLINICAL TRANSPLANTATION, 32(11). -
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.
Busque, S., Scandling, J. D., Lowsky, R., Shizuru, J., Jensen, K., Waters, J., … Strober, S. (2020). Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal. Science Translational Medicine, 12(528). -
The weekend effect and workforce in kidney transplantation.
Scandling, J. D. (2020). The weekend effect and workforce in kidney transplantation. Transplant International : Official Journal of the European Society for Organ Transplantation. -
The center effect in kidney transplantation.
Scandling, J. D. (2020). The center effect in kidney transplantation. Transplant International : Official Journal of the European Society for Organ Transplantation. -
A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients with Uncontrolled Gout Who Have Undergone Kidney Transplantation: Early Data Report
Abdellatif, A., Zhao, L., Peloso, P., Cherny, K., Marder, B., Scandling, J., & Saag, K. (2020). A Multicenter, Open-Label, Efficacy and Safety Study of Pegloticase in Patients with Uncontrolled Gout Who Have Undergone Kidney Transplantation: Early Data Report. ARTHRITIS & RHEUMATOLOGY, 72. -
The Organ Procurement Costs of Expanding Deceased Donor Organ Acceptance Criteria: Evidence from a Cost Function Model.
Cheng, X. S., Held, P. J., Dor, A., Bragg-Gresham, J. L., Tan, J. C., Scandling, J. D., … Roberts, J. P. (2021). The Organ Procurement Costs of Expanding Deceased Donor Organ Acceptance Criteria: Evidence from a Cost Function Model. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
The Importance of Bringing Transplantation Tolerance to the Clinic.
Cosimi, A. B., Ascher, N. L., Emond, J. C., Kaufman, D. B., Madsen, J. C., Miller, J., … Sachs, D. H. (2021). The Importance of Bringing Transplantation Tolerance to the Clinic. Transplantation, 105(5), 935–40. -
Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients.
Jensen, K. P., Hongo, D., Ji, X., Zheng, P., Pawar, R. D., Wu, H.-H., … Strober, S. (2021). Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients. Blood Advances. -
Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
Fehr, T., Hubel, K., de Rougemont, O., Abela, I., Gaspert, A., Gungor, T., … Cippa, P. E. (2022). Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings. Frontiers in Immunology, 13, 796456. -
Pegloticase Treatment for Uncontrolled Gout in Kidney Transplanted Patients: Results of an On-going Multicenter, Open-Label, Efficacy and Safety Study
Abdellatif, A., Zhao, L., Peloso, P. M., Cherny, K., Marder, B., Scandling, J. D., & Saag, K. (2021). Pegloticase Treatment for Uncontrolled Gout in Kidney Transplanted Patients: Results of an On-going Multicenter, Open-Label, Efficacy and Safety Study. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017.
Cheng, X. S., Han, J., Braggs-Gresham, J. L., Held, P. J., Busque, S., Roberts, J. P., … Dor, A. (2022). Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017. JAMA Network Open, 5(3), e221847. -
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.
Wang, A. X., Busque, S., Kuo, J., Singh, U., Roeltgen, K., Pinsky, B. A., … Lenihan, C. R. (2022). SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients. Kidney360, 3(1), 133–143. -
Pegloticase for Uncontrolled Gout in Patients with History of Kidney Transplant: Pharmacokinetics and Immunogenicity in the PROTECT Clinical Trial
Abdellatif, A., Xin, Y., Chamberlain, J., Zhao, L., Cherny, K., Marder, B., … saag, K. (2022). Pegloticase for Uncontrolled Gout in Patients with History of Kidney Transplant: Pharmacokinetics and Immunogenicity in the PROTECT Clinical Trial. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol
Scandling, J., Busque, S., Lowsky, R., Pham, T., Hoppe, R., Jensen, K., … Strober, S. (2022). Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol. TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS. -
Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial.
Abdellatif, A., Zhao, L., Chamberlain, J., Cherny, K., Xin, Y., Marder, B. A., … Saag, K. (2023). Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial. Clinical Transplantation, e14993.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Kidney and Pancreas Transplant Program at Boswell Building Stanford, CA
Stanford, CAKidney and Pancreas Transplant Program at Boswell Building
300 Pasteur Drive, 1st Floor, Suite A160
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Kidney Clinic (Nephrology) at Boswell Building Stanford, CA
Stanford, CAKidney Clinic (Nephrology) at Boswell Building
300 Pasteur Drive , 1st Floor, Suite A175
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(31 reviews)
View More »
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records